Steve Thornton

Director & Chair of Finance Committee at Aerami Therapeutics

Steve brings over 40 years of broad experience, working within large and small pharmaceutical companies, branded and generic, and medical device and drug delivery companies

This experience was gained with several top rank companies, culminating in senior management and executive positions with Eli Lilly, Bayer, and Elan, and in SkyePharma Inc., where he served as President until its sale at which time he was asked to join its BOD.

He has significant experience in sales and marketing, including country management positions, and through his recent executive management positions, he has had responsibility for product development, from formulation, through pre-clinical and clinical development, regulatory, manufacturing, and supply logistics.

He is highly experienced in the areas of in and out licensing of products and has been involved in a variety of startup operations, joint ventures, and acquisitions as well as in the building for sale of well-run companies.

He was the President & CEO of Bioniche Pharma Inc. and oversaw its significant growth through acquisition and internal development programs until its sale to Mylan Corp through a highly professionally run and high return process for its then owners.

Most recently, Steve was the President & CEO of Excelsior Medical LLC, one of the largest suppliers of Saline and Heparin pre-filled syringes and disinfection caps in the US, until its sale to ICU Medical and Medline Industries in late 2015.

Steve has held numerous Board of Director positions and has acted in advisory capacities for both private and public companies.

Timeline

  • Director & Chair of Finance Committee

    Current role

  • CEO